Genentech Targeted Drug Helps Lung Cancer -Study

WASHINGTON (Reuters) - Lung cancer patients given Genentech Inc.'s targeted drug Avastin along with standard chemotherapy lived longer, the U.S. National Cancer Institute said on Monday, sending the company's shares up 25 percent and raising hopes for treatment of an almost always fatal cancer.

Continue to Genentech Targeted Drug Helps Lung Cancer -Study on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz